Cardiology

FDA OKs new anti-clotting drug for heart rhythm disorder

(HealthDay)—A new anti-clotting drug to reduce the risk of dangerous blood clots and strokes in people with a type of heart rhythm disorder has been approved by the U.S. Food and Drug Administration.

Cardiology

Lifestyle the key to gap in cardiac patient outcomes

Patients suffering from the world's most common heart rhythm disorder can have their long-term outcomes significantly improved with an aggressive management of their underlying cardiac risk factors, according to University ...

Cardiology

Implanted heart device linked to increased survival

Implantable cardioverter defibrillators (ICDs) are associated with improved survival among heart failure patients whose left ventricles only pump 30 to 35 percent of blood out of the heart with each contraction, according ...

page 7 from 12